Operating Margin of Inmune Bio, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Inmune Bio, Inc. annual and quarterly Operating Margin in % history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Inmune Bio, Inc. Operating Margin for the quarter ending 31 Mar 2024 was -26210%, a 152% decline year-over-year.
  • Inmune Bio, Inc. annual Operating Margin for 2024 was -304536%, a 1487% decline from 2023.
  • Inmune Bio, Inc. annual Operating Margin for 2023 was -19188%, a 177% decline from 2022.
  • Inmune Bio, Inc. annual Operating Margin for 2022 was -6939%, a 57% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)

Inmune Bio, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -304536% -285348% -1487% 01 Jan 2024 31 Dec 2024
2023 -19188% -12249% -177% 01 Jan 2023 31 Dec 2023
2022 -6939% +9168% +57% 01 Jan 2022 31 Dec 2022
2021 -16107% +95057% +86% 01 Jan 2021 31 Dec 2021
2020 -111164% 01 Jan 2020 31 Dec 2020

Inmune Bio, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2024 -26210% -15810% -152% 01 Jan 2024 31 Mar 2024
Q4 2023 -19188% -12249% -177% 01 Oct 2023 31 Dec 2023
Q3 2023 -12055% 01 Jul 2023 30 Sep 2023
Q2 2023 -9290% 01 Apr 2023 30 Jun 2023
Q1 2023 -10400% 01 Jan 2023 31 Mar 2023
Q4 2022 -6939% 01 Oct 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.